Novartis Opens Tropical Disease Research Institute

Branching out from its Singapore-based Novartis Institute of Tropical Diseases (NITD), the Swiss multinational has opened a scientific initiative in Indonesia to discover and develop treatments for neglected diseases. The company has teamed up with the Eijkman Institute and Hasanuddin University, which are both locally based, to form NEHCRI (the NITD - Eijkman Institute - Hasanuddin University Clinical Research Initiative). In addition to potentially finding cures for some of the world's deadliest infectious diseases, BMI welcomes this development as it will encourage development of a clinical trials industry in one of the world's most populated countries, enabling increased foreign direct

To read the full article, please choose one of the following options: